Danish biotech developing ALS drug opens Newton office
April 17, 2018 at 07:00 AM EDT
Orphazyme, which focuses on rare disease treatments, said that the new office would be led by a former Genzyme executive.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.